A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way ...
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according ...
Because they can be developed rapidly, mRNA vaccines have the potential to bring personalized care, while others can be ...
Moderna's (MRNA) cancer-vaccine rally hit a setback on Thursday as shares slid toward their worst week in three months and Mizuho analyst Jared Holz warned that extreme volatility made the stock a "do ...
The results, which triggered Moderna’s stock to drop, are “really encouraging,” says Karen Knudsen, CEO of the Parker ...
Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results